Adenocarcinoma in situ of the cervix: A prospective study of conization as definitive treatment

Gynecologic Oncology

Volumn 86, Issue 3, 2002, Pages 365-369

  Andersen, Erik Soegaard ^a   Nielsen, Karsten ^a  

^a AALBORG UNIVERSITY HOSPITAL   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOCARCINOMA; ADULT; ARTICLE; CANCER RECURRENCE; CANCER SIZE; CARCINOMA IN SITU; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CYTOLOGY; FEMALE; FOLLOW UP; HUMAN; HUMAN TISSUE; LASER SURGERY; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; SAFETY; TREATMENT OUTCOME; TUMOR BIOPSY; UTERINE CERVIX BIOPSY; UTERINE CERVIX CARCINOMA; UTERINE CERVIX CONIZATION;

EID: 0036446096     PISSN: 00908258     EISSN: None     Source Type: Journal    
DOI: 10.1006/gyno.2002.6758     Document Type: Article

References (31)

1. Hepler TK, Dockerty MB, Randall LM. Primary adenocarcinoma of the cervix. Am J Obstet Gynecol 1952;63:800-8.
2. Friedell GH, McKay DG. Adenocarcinoma in situ of the uterine cervix. Cancer 1953;6:887-97.
3. Gloor E, Ruzicka J. Morphology of adenocarcinoma in situ of the uterine cervix: A study of 14 cases. Cancer 1982;49:294-302.
4. Östör AG, Pagano R, Davoren RAM, Fortune DW, Chanen W, Rome R. Adenocarcinoma in situ of the cervix. Int J Gynecol Pathol 1984;3:179-90.
5. Young RH, Clement PB, Scully RE. Premalignant and malignant glandular lesions of the uterine cervix. In: Clement PB, Young RH, editors. Tumors and Tumor Like Lesions of the Uterine Corpus and Cervix. New York: Churchill Livingstone, 1993.
6. Quizilbash AH. In situ and microinvasive adenocarcinoma of the uterine cervix. Am J Clin Pathol 1975;64:155-70.
7. Christopherson WM, Nealon N, Gray LA. Noninvasive precursor lesions of adenocarcinoma and mixed adenosquamous carcinoma of the cervix uteri. Cancer 1979;44:975-83.
8. Wolk BM, Kime W, Albites V. Simultaneous in situ squamous cell carcinoma and microinvasive adenocarcinoma of the cervix. Int J Gynaecol Obstet 1981;19:69-72.
9. van Roon E, Boon ME, Kurver PJH, Baak JPA. The association between precancerous-columnar and squamous lesions of the cervix: A morphometric study. Histopathology 1983;7:887-96.
10. Buschema J, Woodruf JD. Significance of neoplastic atypicalities in endocervical epithelium. Gynecol Oncol 1984;17:356-62.
11. Hopkins MP, Roberts JA, Schmidt RW. Cervical adenocarcinoma in situ. Obstet Gynecol 1988;71:842-4.
12. Nicklin JL, Wright RG, Bell JR, Samaratunga H, Cox NC, Ward BG. A clinical pathological study of adenocarcinoma in situ of the cervix. The influence of cervical HPV infection and other factors, and the role of conservative surgery. Aust N Z J Obstet Gynaecol 1991;2:179-83.
13. Poynor EA, Barakat RR, Hoskins WJ. Management and follow-up of patients with adenocarcinoma in situ of the uterine cervix. Gynecol Oncol 1995;57:158-64.
14. Wolf JK, Levenbeck C, Malpica A, Morris M, Burke T, Mitchell MF. Adenocarcinoma in situ of the cervix: significance of cone biopsy margins. Obstet Gynecol 1996;88:82-6.
15. Denehy TR, Gregori CA, Been JL. Endocervical curettage, cone margins and residual adenocarcinoma in situ of the cervix. Obstet Gynecol 1997; 90:1-6.
16. Widrich T, Kennedy AW, Myers TM, Hart WR, Wirth S. Adenocarcinoma in situ of the uterine cervix: Management and outcome. Gynecol Oncol 1996;61:304-8.
17. Azodi M, Chambers SK, Rutherford TJ, Kohorn EI, Schwartz PE, Chambers JT. Adeocarcinoma in situ of the cervix: Management and outcome. Gynecol Oncol 1999;73:348-53.
18. Shin CH, Schorge JO, Lee KR, Sheets EE. Conservative management of adenocarcinoma in situ of the cervix. Gynecol Oncol 2000;79:6-10.
19. Östör AG, Duncan A, Quinn M, Rome R. Adenocarcinoma in situ of the uterine cervix: An experience with 100 cases. Gynecol Oncol 2000;79: 207-10.
20. Krivak TC, Rose GS, McBroom JW, Carlson JW, Winter WE, Kost ER. Cervical adenocarcinoma in situ: A systematic review of therapeutic options and predictors of persistent or recurrent disease. Obstet Gynecol Survey 2001;56:567-75.
21. Andersen ES, Arffmann E. Adenocarcinoma in situ of the uterine cervix: A clinico-pathologic study of 36 cases. Gynecol Oncol 1989;35:1-7.
22. Andersen ES, Nielsen K, Pedersen B. The reliability of preconization diagnostic evaluation in patients with cervical intraepithelial neoplasia and microinvasive carcinoma. Gynecol Oncol 1995;59:143-7.
23. Im DD, Duska LR, Rosenheim NB. Adequacy of conization margins in adenocarcinoma in situ of the cervix as a predictor of residual disease. Gynecol Oncol 1995;59:179-82.
24. Schulman H, Cavanagh D. Intraepithelial carcinoma of the cervix: The predictability of residual carcinoma of the uterus from microscopic study of margins of the cone biopsy specimens. Cancer 1961;14:796-800.
25. Schiffer MA, Greeen HJ, Pomerance W, Moltz A. Cervical conization for diagnosis and treatment of carcinoma in situ. Am J Obstet Gynecol 1965;93:889-95.
26. Phelps JY III, Ward JA, Szigeti J II, Boland CH, Mayer AR. Cervical cone margins as predictor for residual dysplasia in post-cone hysterectomy specimens. Obstet Gynecol 1994;84:128-30.
27. Muntz HG. Can cervical adenocarcinoma in situ be safely managed by conization alone? Gynecol Oncol 1996;61:301-3.
28. Bertrand M, Lickrish G, Colgan TJ. The anatomic distribution of cervical adenocarcinoma in situ: Implications for teatment. Am J Obstet Gynecol 1987;157:21-5.
29. Luesley DM, Jordan JA, Woodman CBJ, Watson N, Williams DR, Waddell CA. A retrospective review of adenocarcinoma in situ and glandular atypia of the uterine cervix. Br J Obstet Gynaecol 1987;94:699-703.
30. Cullimore JE, Luesley DM, Rollason TP, Byrne P, Buckley CH, Anderson M, Williams DR, Waddell C, Hudson E, Shafi MI. A prospective study of conization in the management of cervical intraepithelial glandular neoplasia (CIGN) - A preliminary report. Br J Obstet Gynaecol 1992;99:314-8.
31. Kennedy AW, El Tabbakh GH, Biscotti CV, Wirth S. Invasive adenocarcinoma of the cervix following LLETZ (large loop excision of the transformation zone) for adenocarcinoma in situ. Gynecol Oncol 1995;58: 274-7.